X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PANACEA BIOTECH ALEMBIC PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 26.7 79.6 33.5% View Chart
P/BV x 6.1 1.8 343.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALEMBIC PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
PANACEA BIOTECH
Mar-14
ALEMBIC PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs792149 532.4%   
Low Rs44382 538.3%   
Sales per share (Unadj.) Rs167.084.1 198.5%  
Earnings per share (Unadj.) Rs38.2-18.3 -208.5%  
Cash flow per share (Unadj.) Rs42.0-6.7 -626.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs84.983.7 101.4%  
Shares outstanding (eoy) m188.5261.25 307.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.71.4 269.3%   
Avg P/E ratio x16.2-6.3 -256.4%  
P/CF ratio (eoy) x14.7-17.2 -85.3%  
Price / Book Value ratio x7.31.4 527.0%  
Dividend payout %10.50-   
Avg Mkt Cap Rs m116,3837,074 1,645.1%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m4,2141,449 290.8%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m31,4875,154 611.0%  
Other income Rs m55100 55.2%   
Total revenues Rs m31,5425,254 600.4%   
Gross profit Rs m10,060-766 -1,312.8%  
Depreciation Rs m722711 101.6%   
Interest Rs m371,503 2.4%   
Profit before tax Rs m9,356-2,881 -324.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-2-6 26.3%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m2,16017 12,858.3%   
Profit after tax Rs m7,194-1,121 -641.6%  
Gross profit margin %31.9-14.9 -214.9%  
Effective tax rate %23.1-0.6 -3,958.8%   
Net profit margin %22.8-21.8 -105.0%  
BALANCE SHEET DATA
Current assets Rs m15,0663,810 395.4%   
Current liabilities Rs m7,6748,365 91.7%   
Net working cap to sales %23.5-88.4 -26.6%  
Current ratio x2.00.5 431.0%  
Inventory Days Days67156 43.0%  
Debtors Days Days4167 60.4%  
Net fixed assets Rs m8,23714,480 56.9%   
Share capital Rs m37761 615.0%   
"Free" reserves Rs m15,416903 1,707.1%   
Net worth Rs m16,0055,127 312.2%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m24,59419,433 126.6%  
Interest coverage x255.2-0.9 -27,849.3%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.30.3 482.8%   
Return on assets %29.42.0 1,496.9%  
Return on equity %44.9-21.9 -205.5%  
Return on capital %58.73.6 1,613.6%  
Exports to sales %55.724.5 227.3%   
Imports to sales %10.410.2 102.4%   
Exports (fob) Rs m17,5511,264 1,388.7%   
Imports (cif) Rs m3,283525 625.6%   
Fx inflow Rs m17,8111,539 1,157.1%   
Fx outflow Rs m5,318942 564.5%   
Net fx Rs m12,493597 2,091.8%   
CASH FLOW
From Operations Rs m9,304599 1,552.7%  
From Investments Rs m-3,105-438 709.0%  
From Financial Activity Rs m-1,959-303 647.4%  
Net Cashflow Rs m4,240-141 -3,000.7%  

Share Holding

Indian Promoters % 74.1 74.5 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.6 483.3%  
FIIs % 9.1 1.3 700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 23.6 58.9%  
Shareholders   49,328 10,259 480.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   PLETHICO PHARMA  BIOCON LTD  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  AJANTA PHARMA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 24, 2017 12:25 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - ELDER PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS